Research programme: cancer gene therapy - Daewoong
Alternative Names: DWP 451; DWP-Gene; DWPGT1Latest Information Update: 04 Nov 2017
At a glance
- Originator Daewoong Pharmaceutical
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lung cancer; Solid tumours
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Lung-cancer in South Korea (Parenteral)
- 04 Nov 2017 No recent reports of development identified for research development in Solid-tumours in South Korea (Parenteral)
- 10 Oct 2012 Early research is ongoing in South Korea